Skip to main content
Displaying 211 - 220 of 3940
# Title Department Research Year
211 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
212 New nitazoxanide derivatives: design, synthesis, biological evaluation, and molecular docking studies as antibacterial and antimycobacterial agents Department of Pharmaceutical Organic Chemistry 2023
213 NiFe‑based Prussian blue analogue nanopolygons hybridized with functionalized glyoxal polymer as a voltammetric platform for the determination of amisulpride in biological samples Department of Pharmaceutical Analytical Chemistry 2023
214 Non-coding RNA-directed therapeutics in lung cancer: Delivery technologies and clinical applications Department of Industrial Pharmacy 2023
215 Novel Drugs Obtained via Biotransformation—In Memory of the Late Scientists Frieder Schauer and Peter Grunwald 2023
216 Novel fluoroquinolone hybrids as dual DNA gyrase and urease inhibitors with potential antibacterial activity: Design, synthesis, and biological evaluation Department of Pharmaceutical Organic Chemistry 2023
217 Novel piperine carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway Department of Pharmaceutical Organic Chemistry 2023
218 Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain Department of Pharmaceutics 2023
219 Phage therapy, a salvage treatment for multidrug-resistant bacteria causing infective endocarditis 2023
220 Phytochemical analysis and anti-infective potential of fungal endophytes isolated from Nigella sativa seeds Department of Pharmaceutical Organic Chemistry 2023